These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21304320)

  • 41. Acute cholestatic hepatitis induced by Epstein-Barr virus infection in an adult: a case report.
    Khoo A
    J Med Case Rep; 2016 Mar; 10():75. PubMed ID: 27037083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pluriorificial erosive ectodermosis (Stevens-Johnson Syndrome)].
    Landolt RF
    Praxis; 1968 Nov; 57(44):1534-8. PubMed ID: 5757105
    [No Abstract]   [Full Text] [Related]  

  • 43. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Asboe-Hansen sign in toxic epidermal necrolysis.
    Dowling JR; Anderson KL; Huang WW
    Cutis; 2019 Apr; 103(4):E6-E8. PubMed ID: 31116821
    [No Abstract]   [Full Text] [Related]  

  • 45. How best to manage chronic cholestasis.
    Grattagliano I; Floreani A; Ubaldi E; Portincasa P
    J Fam Pract; 2018 Jul; 67(7):E9-E15. PubMed ID: 29989620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
    Beuers U
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject.
    Ader F; Chatellier D; Le Berre R; Morand P; Fourrier F
    Med Mal Infect; 2006 Jul; 36(7):396-8. PubMed ID: 16876362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anicteric form of progressive familial intrahepatic cholestasis (Byler syndrome)].
    Masmoudi A; Hadj-Taieb I; Kammon T; Mseddi M; Boudaya S; Chaabouni M; Hachicha M; Turki H
    Ann Dermatol Venereol; 2008 Mar; 135(3):228-30. PubMed ID: 18374858
    [No Abstract]   [Full Text] [Related]  

  • 50. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
    Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
    Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 52. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients.
    George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J
    South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Lyell's and Stevens-Johnson syndromes].
    Postovit VA; Khazak RS; Kunina TA
    Ter Arkh; 1976; 48(11):126-33. PubMed ID: 1021888
    [No Abstract]   [Full Text] [Related]  

  • 54. Ursodeoxycholic acid's role in avoiding diversionary surgery in idiopathic fibrosing pancreatitis.
    Rosenbaum J; Alex G; Clarnette T
    J Paediatr Child Health; 2009 Nov; 45(11):681-3. PubMed ID: 19845837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Alternative treatment to interferon therapy in chronic viral hepatitis].
    Salmerón Escobar FJ
    Gastroenterol Hepatol; 1995 Oct; 18(8):430-6. PubMed ID: 7584785
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cholestatic liver disease in children].
    Jankowska I; Pawłowska J; Swiatkowska E; Rujner J; Socha J
    Przegl Epidemiol; 2002; 56 Suppl 5():16-21. PubMed ID: 15553067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Stevens-Johnson syndrome plus intrahepatic cholestasis caused by clindamycin or chlorpheniramine].
    Sahagún Flores JE; Soto Ortiz JA; Tovar Méndez CE; Cárdenas Ochoa EC; Hernández Flores G
    Dermatol Online J; 2009 May; 15(5):12. PubMed ID: 19624990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute acalculous cholecystitis as the initial presentation of primary Epstein-Barr virus infection.
    Prassouli A; Panagiotou J; Vakaki M; Giannatou I; Atilakos A; Garoufi A; Papaevangelou V
    J Pediatr Surg; 2007 Jan; 42(1):E11-3. PubMed ID: 17208530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cholestatic Hepatitis Induced by Epstein-Barr Virus in a Pediatric Population.
    Shkalim-Zemer V; Shahar-Nissan K; Ashkenazi-Hoffnung L; Amir J; Bilavsky E
    Clin Pediatr (Phila); 2015 Oct; 54(12):1153-7. PubMed ID: 25676835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Etiology, pathogenesis, clinical picture and treatment of the Stevens-Johnson syndrome].
    Korolev IuF
    Vestn Dermatol Venerol; 1975 Nov; (11):23-5. PubMed ID: 1220373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.